數位治療藥市場:各用途，各產品類型，各銷售管道(BtoB及BtoC)，各地區- 市場規模，佔有率，展望，機會分析，2023年～2030年

市場動態:

慢性病負擔的增加、COVID-19（大流行）的爆發、以患者為中心的醫療保健應用程序的採用增加、數位醫療保健解決方案和技術的採用增加以及政府對預防性醫療保健的日益關注是預計增長的主要因素數位治療市場的增長。

本調查的主要特徵

• 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球數位治療藥市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
• 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
• 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
• 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球數位治療藥市場的主要參與者之企業簡介。
• 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球數位治療藥市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以透過全球數位治療藥市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

• 調查目的
• 前提條件
• 簡稱

第2章 市場概況

• 報告概要
  • 市場定義和範圍
• 摘要整理
• 連貫·機遇·地圖(COM)

第3章 市場動態，法規，趨勢分析

• 市場動態
  • 全球慢性病負擔增加
  • 對患者數據隱私的擔憂
  • 擴大採用數位療法 (DTx)
• 影響分析
• 主要的焦點
• 法規情勢
• 產品上市/核准
• PEST分析
• 波特分析
• 合併·收購情勢

第4章 數位治療藥的全球市場-冠狀病毒(COVID-19)流行的影響

• COVID-19流行病學
• 供給面和需求面的分析
• 經濟影響

第5章 數位治療藥的全球市場:各用途，2018年～2030年

• 糖尿病
• 肥胖
• 心血管疾病(CVD)
• 中樞神經系統(CNS)疾病
• 呼吸疾病
• 戒煙
• 腸胃障礙(GID)
• 其他

第6章 數位治療藥的全球市場:各產品類型，2018～2030年

• 軟體
• 設備

第7章 數位治療藥的全球市場:各銷售管道，2018年～2030年

• 企業間(B2B)
• 僱用主人
• 醫療保健供應商
• 其他
• 企業對消費者(B2C)
• 患者
• 看護者

第8章 數位治療藥的全球市場，各地區，2018年～2030年

• 北美
• 南美
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭情形

• Happify, Inc.
• 2Morrow, Inc.
• Akili Interactive Labs, Inc.
• Click Therapeutics, Inc.
• Fitbit, Inc.(Twine Health, Inc.)

第10章 章節

• 調查手法
• 關於出版社

Digital Therapeutics (DTx) are evidence-based therapeutic interventions driven by the software to prevent, manage, or treat a medical disorder or disease. Digital Therapeutics are a part of the digital healthcare that deliver therapeutic interventions directly to patients via evidence-based, clinically-evaluated software for disease management.

Market Dynamics:

Increasing burden of chronic diseases, the outbreak of COVID-19 (pandemic), increasing adoption of patient-centric healthcare apps, growing adoption of digital healthcare solutions or technologies, and increasing focus toward preventive healthcare by governments are major factors expected to augment the growth of the global digital therapeutics market.

For instance, in February 2022, DynamiCare Health Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the DCH-001, a prescription-only digital therapeutic to treat tobacco use disorder complicating pregnancy and childbirth.

Moreover, in July 2022, AmerisourceBergen planned to launch digital therapeutics (DTx) platform to facilitate access to innovative products. The platform enables doctors to easily access and order prescription and non-prescription DTx through their e-prescribing workflow and monitor patient fulfilment of digital therapeutics and diagnostics.

Key features of the study:

• This report provides in-depth analysis of the global digital therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., and Fitbit, Inc. (Twine Health, Inc.).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital therapeutics market.

Detailed Segmentation:

• Global Digital Therapeutics Market, By Application:
  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others
• Global Digital Therapeutics Market, By Product Type:
  • Software
  • Device
• Global Digital Therapeutics Market, By Sales Channel:
  • Business-to-Business (B2B)
  • Employer
  • Healthcare Provider
  • Others
  • Business-to-Consumer (B2C)
  • Patient
  • Caregiver
• Global Digital Therapeutics Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Happify, Inc.
  • 2Morrow, Inc.
  • Akili Interactive Labs, Inc.
  • Click Therapeutics, Inc.
  • Fitbit, Inc. (Twine Health, Inc.)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By Product Type
  • Market Snapshot, By Sales Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in burden of chronic diseases around the world
  • Concerns about patient data privacy
  • Increasing adoption of digital therapeutics (DTx)
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Digital Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Digital Therapeutics Market, By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Obesity
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Cardiovascular Disease (CVD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Central Nervous System (CNS) Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Respiratory Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Smoking Cessation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Gastrointestinal Disorder (GID)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Digital Therapeutics Market, By Product Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Device
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Digital Therapeutics Market, By Sales Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Business-to-Business (B2B)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Employer
• Healthcare Provider
• Others
• Business-to-Consumer (B2C)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Patient
• Caregiver

8. Global Digital Therapeutics Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)

9. Competitive Landscape

• Happify, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• 2Morrow, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Akili Interactive Labs, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Click Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fitbit, Inc. (Twine Health, Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us